Author | Kassi Jackson


Ill-timed corneal crosslinking led to permanent changes in corneal structure in patients with keratoconus

The study evaluates three separate cases, each of which experienced irreversible changes in their corneal structure caused by challenges in getting timely treatment due to various reasons, including insurance, lost to follow up, and the COVID-19 pandemic.

Data reveals efficacy of bispecific targeting of VEGF, Ang2 pathways

Prof. Anat Loewenstein discusses data regarding the efficacy of faricimab at targeting both the VEGF and Ang2 pathways in patients with neovascular AMD and diabetic macular oedema.

Investigating efficacy of OC-02 to stimulate the trigeminal nerve for the treatment of dry eyes

The study's primary endpoints were to look at increasing Schirmer's scores, as well as eye discomfort score.

Advancing IOL technology for treatment of presbyopia

May 21, 2022

Ora's Caitlin Black, senior director and therapeutic area head of medical devices, talks about the next generation of ophthalmic device therapies and diagnostics, clinical trial updates and new innovations that are most exciting for presbyopia treatment.